Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M410Revenue (TTM) $M15.8Net Margin (%)-1,908.4Altman Z-Score-3.4
Enterprise Value $M425EPS (TTM) $-1.1Operating Margin %-1,859.8Piotroski F-Score1
P/E(ttm)--Beneish M-Score-8.5Pre-tax Margin (%)-1,908.4Higher ROA y-yN
Price/Book8.210-y EBITDA Growth Rate %6.5Quick Ratio4.7Cash flow > EarningsY
Price/Sales25.65-y EBITDA Growth Rate %17.2Current Ratio4.7Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-63.7Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-150.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M271ROIC % (ttm)-442.8Gross Margin Increase y-yN

Gurus Latest Trades with NVAX

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

NVAX is held by these investors:



NVAX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Trizzino JohnSVP, Commercial Operations 2017-01-31Buy3,401$1.1234.82view
Herrmann John A IIISVP, General Counsel 2017-01-31Buy4,960$1.1234.82view
PHILLIPS BARCLAY ASVP, CFO 2017-01-31Buy1,633$1.1234.82view
Glenn Gregory MPresident, R&D 2016-12-07Buy1,000$1.454.14view
Trizzino JohnSVP, Commercial Operations 2016-09-22Buy46,000$2.17-30.41view
DOUGLAS RICHARDDirector 2016-09-21Buy100,000$1.72-12.21view
MCMANUS MICHAEL A JRDirector 2016-09-21Buy30,000$1.61-6.21view
Glenn Gregory MPresident, R&D 2016-09-21Buy1,000$1.65-8.48view
BOUDREAUX GAILDirector 2016-09-20Buy100,000$1.454.14view
PHILLIPS BARCLAY ASVP, CFO 2016-07-31Buy422$4.29-64.8view

Quarterly/Annual Reports about NVAX:

News about NVAX:

Articles On GuruFocus.com
Weekly CFO Buys Highlight: United States Steel Corp, Tuesday Morning Corp, Novavax Inc. Feb 08 2015 
Novavax Inc. Reports Operating Results (10-Q) Nov 08 2010 
Novavax Inc. Reports Operating Results (10-Q) Aug 06 2010 
Novavax Inc. Reports Operating Results (10-Q) May 10 2010 
Novavax Inc. Reports Operating Results (10-Q) Nov 09 2009 
Novavax Inc. Reports Operating Results (10-Q) Aug 10 2009 
Novavax Inc. Reports Operating Results (10-Q) May 11 2009 

More From Other Websites
Biotech Industry Poised for a Breakout in 2017? Today's Reports on Evoke Pharma and Novavax Feb 16 2017
Novavax, Inc. breached its 50 day moving average in a Bullish Manner : NVAX-US : February 14, 2017 Feb 14 2017
Cluster of Insider Buying at Clinical-Stage Vaccine Company, Massive Insider Selling at Analog Chip... Feb 03 2017
Novavax, Inc. breached its 50 day moving average in a Bearish Manner : NVAX-US : January 27, 2017 Jan 27 2017
Novavax starts new clinical trial in bid to prove failed RSV vaccine Jan 19 2017
Novavax Initiates Phase 2 Safety and Immunogenicity Trial of the RSV F Vaccine in Older Adults Jan 19 2017
Novavax Initiates Phase 2 Safety and Immunogenicity Trial of the RSV F Vaccine in Older Adults Jan 19 2017
In Honor Of Friday The 13th, Here Are Some Of The Unluckiest Trades Of 2016 Jan 13 2017
D.C.-area biotech stocks fall on Trump's tough talk on industry Jan 11 2017
Novavax, Inc. – Value Analysis (NASDAQ:NVAX) : January 10, 2017 Jan 10 2017
Novavax, Inc. breached its 50 day moving average in a Bullish Manner : NVAX-US : January 9, 2017 Jan 09 2017
5 Stocks Setting Up for Big Breakouts Jan 06 2017
Novavax to Present at the 35th Annual J.P. Morgan Healthcare Conference Jan 05 2017
Novavax to Present at the 35th Annual J.P. Morgan Healthcare Conference Jan 05 2017
Genocea Announces Positive 6-Month Results from GEN-003 Phase 2b Clinical Trial Jan 05 2017
ETFs with exposure to Novavax, Inc. : January 3, 2017 Jan 03 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)